Brand name: Gabapentin (AN)
Gabapentin (AN) is a medicine containing the active ingredient(s) gabapentin. On this page you will find out more about Gabapentin (AN), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: gabapentin
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Gabapentin (AN) 800 mg film-coated tablet, 100
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults who have not achieved adequate control with standard antiepileptic drugs. Treatment of neuropathic pain.
Table of characteristics
| Active ingredient | |
|---|---|
| Visual appearance |
White to off white, capsule shaped, film coated tablets plain on both side.
Images are the copyright of the Pharmacy Guild of Australia |
| Dosage Form | Tablet, film coated |
| Route of administration | Oral |
| Medicine schedule |
100s: Prescription Only Medicine, or Prescription Animal Remedy
|
There is one type of pack available.
Pack type 1
| Type | Blister Pack |
|---|---|
| Storage temperature | Store below 25 degrees Celsius |
| Storage conditions | See Product information for shelf life |
| Life time | 4 Years |
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 May 2018
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Need more information?
These trusted information partners have more on this topic.
Found 39 results
Pharmacor Gabapentin Tablets - myDr.com.au
Pharmacor Gabapentin Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Chemmart Gabapentin Capsules - myDr.com.au
Chemmart Gabapentin Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Gabapentin Sandoz Capsules - myDr.com.au
Gabapentin Sandoz Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
APO-Gabapentin Capsules - myDr.com.au
APO-Gabapentin Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
GenRx Gabapentin Capsules - myDr.com.au
GenRx Gabapentin Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
GenRx Gabapentin Tablets - myDr.com.au
GenRx Gabapentin Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Pharmacor Gabapentin 400 Capsules - myDr.com.au
Pharmacor Gabapentin 400 Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Neuropathic pain information | myVMC
Neuropathic pain is related to injury to or dysfunction of the nervous system. It does not help protect from injury like physiological pain.
Read more on myVMC – Virtual Medical Centre website
Antiepileptics (antiseizure medications) information | myVMC
Antiepileptics are a class of medicines that prevent the rapid brain stimulation associated with seizures. They are used to treat epilepsy and seizures.
Read more on myVMC – Virtual Medical Centre website
Nupentin Capsules - myDr.com.au
Nupentin Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 48 results
Gabapentin or pregabalin for preventing migraine attacks in adults | Cochrane
Various medicines, collectively termed 'antiepileptics', are used to treat epilepsy. For several years, some of these drugs have also been used for preventing migraine attacks. For the present review, researchers in The Cochrane Collaboration reviewed the evidence about the effects of gabapentin and two related drugs (pregabalin and gabapentin enacarbil) in adult patients ( 16 years of age) with 'episodic' migraine (headache on < 15 days per month). They examined research published up to 15 January 2013, along with three unpublished and previously confidential drug company research reports, and found six relevant studies, five of gabapentin and one of gabapentin enacarbil, both over a wide dose range. The studies showed that neither gabapentin nor gabapentin enacarbil was more effective than placebo at reducing the frequency of migraine headaches. Gabapentin commonly caused side effects, especially dizziness and somnolence (sleepiness). No studies of pregabalin were identified, and research on this drug is desirable.
Read more on Cochrane (Australasian Centre) website
Gabapentin for acute postoperative pain in adults | Cochrane
Gabapentin is a medicine used primarily to treat epilepsy and also pain caused by damage to nerves (neuropathic pain). Gabapentin is not normally used to treat pain due to injury or pain after an operation; it is debatable whether gabapentin is an effective pain medicine under such circumstances. We aimed to investigate whether gabapentin is effective in the treatment of acute postoperative pain in adults. We identified four unpublished clinical trials with 370 participants who received either gabapentin or placebo (sugar pill). Gabapentin 250 mg does provide some relief in acute postoperative pain but it is not as good as some other medicines commonly used in this setting, particularly ibuprofen, diclofenac, and naproxen, and probably paracetamol (acetaminophen) alone or in combination with a weak opioid.
Read more on Cochrane (Australasian Centre) website
Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for preventing migraine attacks in adults | Cochrane
Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for preventing migraine attacks in adults
Read more on Cochrane (Australasian Centre) website
Gabapentin or pregabalin for preventing migraine attacks in adults | Cochrane
Read more on Cochrane (Australasian Centre) website
Gabapentin for chronic neuropathic pain and fibromyalgia in adults | Cochrane
Read more on Cochrane (Australasian Centre) website
Gabapentin for chronic neuropathic pain and fibromyalgia in adults | Cochrane
Read more on Cochrane (Australasian Centre) website
Gabapentin as an add-on for drug-resistant partial epilepsy | Cochrane
This review is an update of a previously published review and is now currently up to date as from 18/07/2013.
Read more on Cochrane (Australasian Centre) website
Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for preventing migraine attacks in adults | Cochrane
Read more on Cochrane (Australasian Centre) website
Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease | Cochrane
A cramp is a sudden, involuntary painful contraction of a muscle. Many people with amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), experience cramps during the course of the disease. These range from mild cramps that do not affect daily activities and sleep, through to very severe, painful cramps. Some medications that are used to treat cramps in people with no medical condition or with conditions other than ALS have been tested in ALS clinical trials. These medicines include vitamin E, creatine, quinidine, and gabapentin. Other medications such as quinine sulfate, magnesium, lioresal, dantrolene, clonazepam, diphenylhydantoin, and gabapentin have been used to treat cramps in people with ALS but their effectiveness is unknown. In 2006 and 2010 the US Food and Drugs Administration issued warnings concerning the use of quinine sulfate, which was the previously most widely prescribed medication for cramps in the US. This review sought to find out how effective medications and physical treatments for cramps are for people with ALS. The reviewers identified 20 randomised controlled trials in people with ALS comprising a total of 4789 participants. Only one trial, of the drug tetrahydrocannabinol (THC), directly investigated the effectiveness of an intervention for cramps. Thirteen randomised controlled ALS trials investigated cramps secondarily among other variables. The medications comprised vitamin E, baclofen, riluzole, L-threonine, xaliproden, indinavir, and memantine. Six randomised controlled ALS trials investigated cramps as adverse events. The medications comprised creatine, gabapentin, dextromethorphan, quinidine and lithium. None of the 20 studies could demonstrate any benefit, but the studies were small. Current evidence on the treatment of cramps in ALS is lacking and more research is needed.
Read more on Cochrane (Australasian Centre) website
Anticonvulsants for fibromyalgia | Cochrane
Researchers in The Cochrane Collaboration conducted a review of research about the effects of anticonvulsants (antiepileptic drugs) on fibromyalgia (FM). After searching for all relevant studies, they found eight studies with up to 3579 people. The anticonvulsants that they studied were gabapentin, lacosamide, levetiracetam and pregabalin. They found reliable conclusions for pregabalin only.
Read more on Cochrane (Australasian Centre) website
